Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeres Power Regulatory News (CWR)

Share Price Information for Ceres Power (CWR)

Share Price is delayed by 15 minutes
Get Live Data
637.50    -12.50 (-1.92%)
Bid:
638.00
Ask:
640.00
Spread: 2.00 (0.313%)
Market Cap: £1.25b
CWR Live PriceLast checked at - London Stock Exchange

Intraday Ceres Power Share Chart

Directorate Change

21 Jan 2010 07:00

RNS Number : 8897F
Ceres Power Holdings plc
21 January 2010
 



21 January 2010

Ceres Power Holdings plc

('Ceres', 'Ceres Power' or the 'Company')

Ceres Power appoints Technology Director

Ceres Power Holdings plc is pleased to announce the appointment of Dr Phil Whalen to its Board as Technology Director.

Phil joined Ceres in July 2009 having been Chief Technology Officer of Invensys plc and previously Director of Technology Strategy at Honeywell International Inc. Phil is responsible for technology development, advanced engineering and control systems. He has over twenty years experience of developing and leading global technology teams across a variety of technologies, including engineered ceramics and control systems. Phil has extensive experience in developing and commercialising new technologies across a wide range of international markets.

Phil is an American citizen and received a PhD in Ceramic Science and Engineering from Rutgers University, New Jersey. 

Brian Count, Chairman of Ceres Power commented: 

"I am delighted to welcome Phil to our Board. His strong background in leading and developing technology teams and bringing new technology products to market will prove invaluable as Ceres Power progresses towards the mass market launch of our domestic CHP product"

Information required pursuant to Schedule 2 (g) of the AIM Rules:

Dr Phil Whalen is aged 51

He currently holds the following directorships:

Ceres Power Limited

Ceres Intellectual Property Company Limited 

Phil holds no shares in Ceres Power. He holds 212,500 options over shares in Ceres Power at a price of £2.00 per share. The exercise of these share options is subject to the following performance targets based on growth in the Company's share price;

* 25% of the options will become exercisable if the Company's share price exceeds £4 for a period of twenty consecutive dealing days between the second and tenth anniversary of the grant 

* 37.5% of the options will become exercisable if the Company's share price exceeds £5 for a period of twenty consecutive dealing days between the third and tenth anniversary of the grant 

* 37.5% of the options will become exercisable if the Company's share price exceeds £6 for a period of twenty consecutive dealing days between the fourth and tenth anniversary of the grant

Phil held no other directorships in the last five years. 

There is no other information required to be disclosed pursuant to Schedule 2 (g) of the AIM Rules.

For further information please contact:

Ceres Power Holdings plc

Tel. +44 (0)1293 400 404

Peter Bance, Chief Executive Officer

Rex Vevers, Finance Director

 

 

 

Morgan Stanley

Tel. +44 (0)20 7425 8000

Peter Moorhouse/Alastair Walmsley

Gavin Anderson & Company

Tel. +44 (0)20 7074 1800

Robert Speed/Ken Cronin/Deborah Walter 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUMCGUPUGRU
Date   Source Headline
1st Jun 20264:00 pmRNSHolding(s) in Company
29th May 202610:00 amRNSTotal Voting Rights
14th May 20263:31 pmRNSDirectorate change
14th May 20263:30 pmRNSResult of AGM
8th May 20263:30 pmRNSHolding(s) in Company
8th May 20263:30 pmRNSGrant of Share Options under the Sharesave Scheme
8th May 202610:30 amRNSHolding(s) in Company
6th May 20269:00 amRNSHolding(s) in Company
5th May 202611:15 amRNSHolding(s) in Company
1st May 20261:15 pmRNSDirector/PDMR Shareholding
1st May 202610:00 amRNSHolding(s) in Company
30th Apr 20261:20 pmRNSHolding(s) in Company
30th Apr 20261:20 pmRNSHolding(s) in Company
30th Apr 202610:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSDelta Electronics & Centrica partnership
29th Apr 202611:00 amRNSHolding(s) in Company
21st Apr 20267:00 amRNSChange of Adviser
17th Apr 20262:30 pmRNSGrant of Long Term Incentive Plan (“LTIP”) Awards
15th Apr 202610:30 amRNSCapital markets event
14th Apr 202611:00 amRNSNotice of AGM & Publication of Annual Report
31st Mar 202610:00 amRNSTotal Voting Rights
26th Mar 20267:02 amRNSCeres and Centrica sign a strategic partnership
26th Mar 20267:00 amRNSFinal results for the year ended 31 December 2025
23rd Mar 20267:00 amRNSNotice of Capital Markets Event
9th Mar 202611:00 amRNSHolding(s) in Company
27th Feb 202612:00 pmRNSTotal Voting Rights
24th Feb 20267:00 amRNSNotice of Results
20th Feb 20269:30 amRNSHolding(s) in Company
16th Feb 20261:00 pmRNSHolding(s) in Company
5th Feb 20266:15 pmRNSHolding(s) in Company
4th Feb 202612:00 pmRNSHolding(s) in Company
30th Jan 202610:00 amRNSTotal Voting Rights
9th Jan 20262:00 pmRNSBlock listing Interim Review
8th Jan 20264:45 pmRNSHolding(s) in Company
6th Jan 202612:00 pmRNSHolding(s) in Company
31st Dec 202510:00 amRNSTotal Voting Rights
31st Dec 202510:00 amRNSTotal Voting Rights
18th Dec 20254:30 pmRNSHolding(s) in Company
18th Dec 20254:30 pmRNSHolding(s) in Company
15th Dec 20252:30 pmRNSHolding(s) in Company
28th Nov 202510:00 amRNSTotal Voting Rights
6th Nov 20253:10 pmRNSHolding(s) in Company
5th Nov 20257:00 amRNSWeichai signs manufacturing licence for SOFC power
31st Oct 20254:15 pmRNSHolding(s) in Company
31st Oct 202510:00 amRNSTotal Voting Rights
27th Oct 20256:00 pmRNSAlpha Group International
15th Oct 202510:00 amRNSHolding(s) in Company
7th Oct 20259:30 amRNSHolding(s) in Company
6th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 202511:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.